Related Posts

• 
  Hippocampal Volume as an Enrichment Biomarker in Trials of Patients with Mild Cognitive Impairment
• 
  Facilitating rapid data and information sharing by establishing a sustainable, integrated, and standardized platform advancing knowledge to enable expedited drug development
• 
  Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments
• 
  “Improving Clinical Trials to Deliver Better Treatments,” as featured in the Spring 2018 edition of “Progress, the research magazine of Parkinson’s UK”
• New Collaboration Seeks to Speed Huntington’s Disease Drug Licensing